Physiochemical changes in HDL3 after bezafibrate treatment: Influence on free cholesterol efflux from human fibroblasts

Cardiovascular Drugs and Therapy

Volumn 11, Issue 5, 1997, Pages 653-658

  La Ville, Agnes E ^a   Solà, Rosa ^a   Motta, Claude ^b   Plana, Núria ^a   Heras, Mercedes ^a   Ribalta, Josep ^a   Masana, Lluís ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b HÔTEL DIEU   (France)

Author keywords

Bezafibrate; Free cholesterol efflux; HDL3 composition; Hypertriglyceridemia

Indexed keywords

ANTILIPEMIC AGENT; BEZAFIBRATE; CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL; HIGH DENSITY LIPOPROTEIN 3; LIPOPROTEIN;

ADULT; ANISOTROPY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CLINICAL ARTICLE; CLINICAL TRIAL; FIBROBLAST; HUMAN; HYPERTRIGLYCERIDEMIA; MULTIVARIATE ANALYSIS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN CONTENT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; MALE; METABOLISM; MIDDLE AGED; SKIN;

ADULT; ANTILIPEMIC AGENTS; BEZAFIBRATE; CELLS, CULTURED; FIBROBLASTS; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL3; MALE; MIDDLE AGED; SKIN;

EID: 0031283049     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007734924101     Document Type: Article

References (32)

1. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglycerides and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 1992;85:37-45.
2. Assmann G, Schulte H. Relation of high density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 1992;70:733-737.
3. Eisenberg S, Gavish D, Oschry Y, Fainaru M, Deckelbaum RJ. Abnormalities in very low, low, and high density lipoproteins in hypertriglyceridemia. Reversal towards normal with bezafibrate treatment. J Clin Invest 1984;74:470-482.
4. Hunninghake DB, Peters JR. Effect of fibric acid derivatives on blood lipid and lipoprotein levels. Am J Med 1987;83:44-49.
5. Deckelbaum RJ, Shipley GG, Small DM. Structure and interactions of lipids in human plasma low density lipoprotein. J Biol Chem 1977;252:744-754.
6. Solà R, Baudet MF, Motta C, Maillé M, Bosnier C, Jacotot B. Effects of dietary fats on the fluidity of human high-density lipoprotein: Influence of the overall composition and phospholipid fatty acids. Biochim Biophys Acta 1990;1043:43-51.
7. 3. Arterioscler Thromb 1993;13:958-966.
8. La Ville AE, Sola R, Balanya J, Turner PR, Masana L. In vitro oxidised HDL is recognised by the scavenger receptor of macrophages: Implications for its protective role in vivo. Atherosclerosis 1994;105:179-189.
9. Shumaker UN, Pupione DL. Sequential flotation ultracentrifugation. Methods Enzymol 1986;128:155-170.
10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951;193:265-275.
11. Shinitzky M, Yuli I. Lipid fluidity at the submacroscopic level: Determination by fluorescence polarization. Chem Phys Lipids 1982;30:261-282.
12. Lentz BR, Moore BM, Barrow DA. Light-scattering effects in the measurement of membrane microviscosity with diphenylhexatriene. Biophys J 1979;25:489-494.
13. Eisinger J, Flores J. Fluorometry of turbid and absorbant samples and the membrane fluidity of intact erythrocytes. Biophys J 1985;48:77-84.
14. Grunberger D, Haimmovitz R, Shinitzky M. Resolution of plasma membrane fluidity in intact cells labelled with diphenylhexatriene. Biochim Biophys Acta 1982;688:764-774.
15. Brown MS, Ho YK, Goldstein JL. The cholesterol ester cycle in macrophages foam cells: Continual hydrolysis and reesterification of cytoplasmic cholesterol esters. J Biol Chem 1980;255:9344-9352.
16. Stein Y, Glangeaud MC, Fainaru M, Stein O. The removal of cholesterol from aortic smooth muscle cells in cultured and Landschutz ascites cells by fractions of human high-density apolipoprotein. Biochim Biophys Acta 1975;380:106-118.
17. Esteva O, Baudet MF, Lasserre M, Jacotot B. Influence of the fatty acid composition of high density lipoprotein phospholipids on the cholesterol efflux from cultured fibroblasts. Biochin Biophys Acta 1986;875:174-182.
18. Rothblath GH, Bamberger M, Phillips MC. Reverse cholesterol transport. Methods Enzymol 1986;129:628-644.
19. Dole VP. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest 1955;35:150-154.
20. Bates SR, Rothblat TH. Regulation of cellular sterol flux and synthesis by human serum proteins. Biochem Biophys Acta 1974;360:38-55.
21. Norusis MJ. SPSS/PC + for the IBM PC/XT/AT. Chicago, IL, SPSS Inc., 1986.
22. Oram JF. Effects of high density lipoprotein subfractions on cholesterol homeostasis in human fibroblasts and arterial smooth muscle cells. Arteriosclerosis 1983;3:420-432.
23. Ericsson CG, Hamsten A, Nilsson J, Grip L, Svane B, Faire U. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 1996;347:849-853.
24. Fournier N, de la Llera M, Burkey M, et al. Role of HDL phospholipid in efflux of cell cholesterol to whole serum: Studies with human apoA-I transgenic rats. J Lipid Res 1996;37:1704-1711.
25. Stein O, Fainaru M, Stein Y. The role of lysophosphatidylcholine and apolipoprotein A in the cholesterol-removing capacity of lipoprotein-deficient serum in tissue culture. Biochim Biophys Acta 1979;574:495-504.
26. Fielding PE, Kawano M, Catapano AL, Zoppo A, Marcovina S, Fielding CJ. Unique epitope of apo A-I expressed in pre-β high density lipoprotein and its role in the catalysed efflux of cellular cholesterol. Biochemistry 1994;33:6981-6985.
27. Davidson WS, Gillote KL, Lund-Katz S, Johnson WJ, Rothblat GH, Phillips MC. The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol. J Biol Chem 1995;270:5882-5890.
28. Vitello LB, Scanu AM. Studies on human high density lipoprotein. Self-association of apolipoprotein A-I in aqueous solutions. J Biol Chem 1976;251:1131-1136.
29. Homma Y, Ozawa H, Kobayashi T, Yamaguchi H, Sakane H, Mikami Y, Nakamura H. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltranferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia. Atherosclerosis 1994;106:191-201.
30. Brinton EA, Oram JF, Bierman EL. The effect of variations in lipid composition of high-density lipoprotein on its interaction with receptors on human fibroblasts. Biochim Biophys Acta 1987;920:68-75.
31. Shinitzky M. Membrane fluidity in malignancy adversative and recuperative. Biochim Biophys Acta 1984;738:251-261.
32. Shinitzky M, ed. Physiology of Membrane Fluidity Boca Raton. FL: CRC Press, 1984.